Neervannan Seshadri sold TARS
March 4, 2026 · Form 4 insider transaction
Neervannan Seshadri sold 8,366 shares of Tarsus Pharmaceuticals, Inc. at $76.67 per share, a transaction worth $641.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
8,366
Price
$76.67
Total value
$641.4K
InsiderNeervannan Seshadri
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 4, 2026
Filing dateMarch 5, 2026
Shares owned after70,817
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.